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founding factor in the assessment of olfaction, e.g. in NC. 
Furthermore, our results confirm that olfaction is impaired in 
PD, whereas it is normal in RLS. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Olfactory deficit is a well-known early symptom of 
Parkinson disease (PD)  [1] . REM sleep behavior disorder 
(RBD), which often precedes the clinical presentation of 
PD and other neurodegenerative disorders  [2, 3] , has also 
been associated with hyposmia  [4, 5] . This is explained 
by the observations that during the premotor stages of 
PD neuropathological lesions initially occur in the ante-
rior olfactory nucleus and the dorsal motor nucleus of 
the glossopharyngeal and vagal nerves, followed by le-
sions in the pontine tegmentum, including the coerule-
us-subcoeruleus complex and the pedunculopontine nu-
cleus  [6, 7] .
 Decreased olfactory threshold has recently been de-
scribed in narcolepsy patients with and without RBD  [8–
10] . In the largest and most recent study of olfactory func-
tion in narcolepsy  [10] , olfactory deficit in narcolepsy pa-
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 Abstract 
 Background: We aimed to investigate the differential roles 
of hypocretin versus dopamine dysfunction versus excessive 
daytime sleepiness (EDS) in the development of hyposmia. 
Olfaction in patients with Parkinson disease, restless leg syn-
drome, narcolepsy with cataplexy, EDS, and healthy controls 
was compared.  Methods: Sixty-six subjects participated in 
the study: 14 with PD, 13 with NC, 12 with RLS, 8 with EDS, 
and 20 healthy controls. Olfaction was tested using stan-
dardized Sniffin’Sticks test. Sleepiness was assessed using 
Karolinska, Stanford and Epworth sleepiness scales.  Results: 
Olfactory discrimination correlated negatively with subjec-
tive momentary sleepiness. A significant deficit in olfaction 
was found in PD patients with respect to all other groups in 
all olfactory domains. No significant differences were found 
between the other groups.  Conclusion: We could not con-
firm decreased olfaction in patients with NC. Yet the signifi-
cant correlation between momentary sleepiness and olfac-
tory function suggests that sleepiness is a potential con-
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tients was mild to moderate and present in about a 
quarter of subjects.
 Narcolepsy-cataplexy (NC) is a disabling life-long 
sleep-wake disorder, characterized by excessive daytime 
sleepiness (EDS) and sudden loss of muscle tone triggered 
by emotions (cataplexy)  [11] . It is tightly associated with 
the loss of hypocretin (also called orexin) neurons in the 
posterior hypothalamus  [12–14] . Hypocretin is a hypo-
thalamic neuropeptide, involved in sleep-wake regula-
tion, motor function, and food intake  [15] . The hypocre-
tin ligands and their receptors, except in the hypothala-
mus, are present at all levels of the olfactory system  [16, 
17] . It has been suggested that hypocretin increases olfac-
tory sensitivity in rats  [18] and its loss causes olfactory 
dysfunction in patients with NC  [19] . A degeneration of 
the hypocretin olfactory nasal mucosa cells in NC pa-
tients was assumed and thought to support the hypoth-
esis that narcolepsy is a neurodegenerative disease  [8] . 
This assumption, however, has not been confirmed in au-
topsy studies.
 Partial hypothalamic hypocretin cell loss was also re-
ported in patients with PD  [20, 21] . It was suggested that 
this partial loss might contribute to EDS in PD.
 Dopamine dysfunction is probably also relevant in 
restless legs syndrome (RLS), a sleep-related movement 
disorder. Similar to PD, decreased dopamine activity was 
shown in PET studies  [22, 23] . In addition, the disorder 
responds very well to dopaminergic medication. So far, 
two studies examined olfactory function in RLS patients, 
showing normal results  [24, 25] .
 Together with these neurotransmitter systems, vigi-
lance, attention and sleep are important contributors for 
perception including olfaction. It has been shown that 
smell identification performance worsens after sleep de-
privation  [26] . Furthermore olfactory event-related po-
tentials have a circadian rhythm opposite to sleepiness 
 [27] , and selective olfactory stimuli do not lead to arous-
als during nocturnal sleep  [28, 29] . The possible associa-
tion between EDS and olfaction has not yet been exam-
ined.
 Thus, is hyposmia due to dopamine or hypocretin dys-
function? Does sleepiness influence olfaction?
 With this study, we wanted to test for olfaction defi-
cits in patients with dopamine and/or hypocretin dys-
function. We hypothesized that decreased olfaction in 
NC and EDS patients might be partially due to sleepi-
ness-associated attention and concentration impair-
ment.
 Subjects and Methods 
 To test our hypothesis, we analyzed olfaction and sleepiness in 
patients with NC, PD, RLS, EDS not caused by narcolepsy, and 
healthy control subjects.
 The study was approved by the local ethics committee and all 
subjects provided written informed consent.
 Patient Characteristics ( table 1 ) 
 We examined 13 patients with PD, 13 patients with NC, 12 pa-
tients with RLS, 8 patients with EDS, and 20 control subjects.
 Patients with PD were diagnosed according to the Queen 
Square British Brain Bank Criteria  [30] and only patients with a 
Hoehn and Yahr score  ^  III were included. NC and RLS were di-
agnosed according to the International Classification of Sleep Dis-
orders, second Edition, ICSD-2  [31] . All narcolepsy subjects also 
suffered from typical cataplexy, tested positive for HLA DQB1 * 0602 
and had hypocretin (orexin) levels in the cerebrospinal fluid (CSF) 
either undetectable or low (measured in all but one patient). The 
EDS group was composed of patients with different disorders such 
as obstructive sleep apnea syndrome (SAS) (n = 2), behaviorally 
induced insufficient sleep syndrome (n = 4) and unclear causes of 
sleepiness (n = 2). All patients with EDS had ESS scores  6 10 and 
a MSL  ! 8 min. MSL was tested in all but one EDS patients.
 Control subjects were screened for sleep-wake disorders using 
extensive sleep-questionnaires, excluding RLS, EDS, insomnia, 
possible OSAS, and parasomnias. Subjects with sleep-wake disor-
ders were excluded.
 General exclusion criteria for both patients and control sub-
jects included cognitive impairment, gestation, upper airways in-
fections, active allergic diseases of the upper airways, and recent 
Table 1. D emographic characteristics, KSS and ESS scores of the subjects
n M/F Mean age 8 SD
years
Range
years
KSS 8 SD ESS 8 SD
PD 13 8/5 61.586.7 52–73 4.382.4 7.9284.79
NC 13 8/5 45.9814.9 22–65 3.682.5 14.1584.08
RLS 12 4/8 50.2818.6 24–81 3.182.3 5.8284.4
EDS 8 7/1 46.7817.3 19–72 6.182.3 14.7883.03
Controls 20 8/12 52.5816.6 24–76 2.381.6 6.6183.47
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use of upper airway medications. Smoking was not among the 
exclusion criteria since it was not proven to significantly affect 
olfaction  [10, 32] (as confirmed by our results).
 Drug therapy: Nine patients with PD were treated with levodo-
pa with or without additional dopamine agonists, four received 
no dopaminergic medication. Four RLS patients were treated 
with dopaminergic agents, and 8 were untreated. Dopaminergic 
medication taken by PD and RLS patients was converted into do-
pamine equivalents.
 Ten NC patients received treatment for EDS including sodium 
oxybate, modafinil, methylphenidate, or combinations. Two pa-
tients were also treated with venlafaxin.
 Olfactory Testing 
 Olfaction was tested using Sniffin’Sticks, a standardized test 
already used in previous studies  [8, 10] . Subjects were tested dur-
ing daytime by the two first authors in a regularly ventilated, 
closed room of neutral smell. A gap of at least 1 h was observed 
between the time points of testing and of last food intake.
 Sniffin’Sticks are felt-tip pens filled with odorants in different 
concentrations. The test is composed of three parts, testing for 
olfactory threshold, discrimination, and identification. Subjects 
were blindfolded during testing. Each test was performed first bi-
laterally, then separately on the left and right nostril.
 The test for threshold consists of 16 triplets of sticks. In each 
triplet one stick holds a specific concentration of N-butanol, dis-
solved in polypropylene glycol, whereas the other two are filled 
with solvent. N-butanol concentration decreases from stick num-
ber 1 to stick number 16. Sticks with and without odorant are 
continuously presented to the subject in random order, but fol-
lowing an increasing or decreasing odor concentration staircase. 
Failure to recognize the odorant during decreasing concentra-
tion, as well as double recognition during increasing concentra-
tion leads to an inversion of the staircase. The average of the last 
four of eight staircase inversions was used as the final value.
 The test for discrimination consists of 16 triplets of sticks, each 
of which contains two sticks with the same odor and one that is 
different. The subject must recognize which stick smells differ-
ently. The number of correctly evaluated triplets gives the dis-
crimination score.
 The test for identification consists also of 16 sticks containing 
different familiar odors to be identified, namely orange, leather, 
cinnamon, peppermint, banana, lemon, liquorice, turpentine, 
garlic, coffee, apple, clover, pineapple, rose, aniseed, and fish. The 
subject must identify the odor from a multiple choice of four pos-
sibilities per odor. The number of correct identifications gives the 
identification score.
 The sum of the scores of the three sections in the Sniffin’Sticks 
test is called the Threshold-Discrimination-Identification sum 
score, or TDI score, which gives a general parameter for olfactory 
function in one subject and was used in previous studies.
 Assessment of Sleepiness and Attention 
 Sleepiness and sleep characteristics were assessed using sub-
jective and objective methods. Subjective momentary sleepiness 
was assessed for all subjects by using two different questionnaires: 
the Karolinska sleepiness scale (KSS  [33] ), and the Stanford sleep-
iness scale (SSS  [34] ), which describe increasing degrees of sleep-
iness respectively from 1 to 9 and from 1 to 7. Subjective EDS was 
assessed using the Epworth sleepiness scale (ESS), which mea-
sures the estimated likelihood of falling asleep during specific 
daily activities over the last four weeks. Scores above 10/24 indi-
cate EDS.
 A subset of patients with NC and EDS underwent multiple 
sleep latency tests (MSLT), which objectively measure momentary 
EDS.
 Since attention may have an influence on olfaction perfor-
mance, 34 patients and controls were tested for attention using the 
d2 test of attention. In this 4’20’’ test, subjects must check as many 
marked ‘d’s as possible on a piece of paper. The number of checked 
letters and the number of mistakes allows objectifying the mo-
mentary attention of the subject.
 Statistics 
 Quantitative data and graphics are presented as mean  8 SD. 
Comparison of means was performed using one-way ANOVA. 
Multiple comparison post-hoc tests were adjusted with the Bonfer-
roni formula. In order to analyze data independently from the ma-
jor confounding factor age, we created a second set of data adjust-
ing the test scores for age using a linear regression that was calcu-
lated on data from all groups except PD patients. As hyposmia is a 
well-known disease dependent symptom in PD, data from this 
group would have distorted the adjustment. The age dependent 
decay of olfactory performance has already been described as a 
mainly linear process  [25, 35] , whereas others  [35] found that such 
decline is slightly increased with older age. Our data suggested a 
linear regression throughout the curve as suggested by the graph 
in  figure 1 , and scores were adjusted consequently. The adjusted 
scores are the addition of the tested score and the regression coef-
ficient multiplied by the subject’s age. The calculated coefficients 
were 0.127 for the TDI score, 0.035 for threshold, 0.06 for discrim-
ination, and 0.032 for identification. Correlations were calculated 
using bivariate Pearsons’s Correlation. We excluded PD patients 
from all statistical testing except direct group comparisons.
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 Fig. 1. Observed TDI scores depend on age in linear manner. PD 
patients are excluded. 
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 Results 
 Comparison of Groups 
 We found an inverse correlation between age and ol-
factory test results (r = –0.497 for the TSI score, –0.294 
for threshold, –0.486 for discrimination, –0.239 for 
identification; p  ! 0.05). Thus we adjusted for age as de-
scribed above before performing further statistical anal-
yses.  Figure 2 shows the mean test results for the differ-
ent subject groups before adjustment. One-way ANOVA 
testing before adjustment showed a significant differ-
ence between PD patients and all other groups in all 
three sections of olfaction testing and the TDI sum-
score (p  ! 0.001). When applying Bonferroni’s correc-
tion to multiple comparisons post-hoc test, the differ-
ences remained significant for all tests except for thresh-
old and TDI score between the PD and EDS groups (p = 
0.46 and 0.272). Differences in discrimination and iden-
tification remained significant. No significant differ-
ence was found between patients with narcolepsy, RLS, 
EDS and healthy controls.
 Sleepiness and Olfaction 
 We found significant correlations between subjective 
momentary sleepiness and the TSI score. The TSI score 
correlated negatively to the SSS score (r = –0.37, p = 0.004) 
and to the KSS score (r = –0.359, p = 0.004). The scores 
for the discrimination sub-test also correlated to momen-
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 Fig. 2.  a–d Mean TDI and subtest scores divided by groups. PD patients score significantly lower test resuls. 
Significant differences are indicated by asterisks. 
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tary sleepiness (r = –0.366, p = 0.008 for SSS; r = –0.310, 
p = 0.027 for KSS). Similar results concerning long-term 
daytime sleepiness (ESS) as well as correlations between 
threshold or identification testing and momentary sleep-
iness did not reach statistical significance.
 Whereas both ESS and NC groups showed an in-
creased general sleepiness score (ESS, p  ! 0.001), only the 
EDS group also showed a significantly higher momen-
tary sleepiness (KSS, p = 0.002) compared to controls. See 
 table 1 for mean sleepiness results.
 Within the narcolepsy group, three of thirteen pa-
tients were not treated with stimulants or sodium oxy-
bate. In comparison to the treated patients, this subgroup 
showed not only elevated mean sleepiness scores (SSS 4.3 
vs. 1.4, KSS 6.6 vs. 2.7, ESS 17.7 vs. 13.1), but also reduced 
mean olfactory scores (threshold 6.8 vs. 9.2, discrimina-
tion 15.1 vs. 16.7, identification 12.5 vs. 15.5).
 Olfaction and Other Factors 
 Since marked asymmetry of the symptoms is a hall-
mark of PD, we compared olfaction scores between ipsi- 
and contralateral nostrils using the paired sample t test, 
but we found no difference.
 In the control group, as well as in all patients’ groups 
olfaction did not depend on smoking, gender, or self es-
timated olfactory capability.
 Levodopa-equivalent dose in PD and RLS patients did 
not correlate with olfactory performance.
 The number of checked ‘d’ on the d2 test correlated 
negatively with age (r = –0.729, p  ! 0.001), while no direct 
correlation was found between attention and olfaction 
once data were adjusted for age.
 Discussion 
 There are three main findings of our systematic, pro-
spective, controlled single-center study. The first is a neg-
ative correlation between momentary sleepiness and ol-
factory performance. The second is the confirmation of 
decreased, respectively normal olfaction in patients with 
PD and RLS. The third is the inability to confirm hypos-
mia for patients with NC in comparison to healthy con-
trols.
 Following the hypothesis that sleepiness might im-
pair olfactory function, we analyzed the impact of sleep-
iness on olfactory test results. Our findings confirmed 
our hypothesis, most importantly the presence of sig-
nificant correlations between subjective momentary 
sleepiness and discrimination testing. In the same direc-
tion we found better testing scores for olfaction in treat-
ed compared to untreated NC patients who were also 
sleepier.
 Like ours, the largest previous study on olfaction in 
NC using Sniffin’Sticks  [10] showed significantly differ-
ent scores only in the discrimination subtest, which may 
be the subtest requiring most attention and concentra-
tion, and therefore the first to be influenced by sleepi-
ness. We could not show an association between olfac-
tory performance and attention using d2 test of atten-
tion. However, others found that odor identification 
ability positively predicts performance on the Wiscon-
sin card-sorting test (WCST), a test that measures atten-
tion and executive function, following sleep deprivation 
 [36] .
 Correlations between scores in the widely used ESS 
and olfaction impairment were not significant. This in-
dicates that testing is influenced by momentary sleepi-
ness (KSS, SSS) rather than by general sleepiness within 
the last four weeks as evaluated by the ESS. This is sup-
ported by the findings of others that show a slight de-
crease in olfactory performance after sleep deprivation 
and increase of the SSS score  [26] . Our patients did not 
undergo acute sleep deprivation and were probably less 
sleepy then the patients of Killgore and McBride.
 In contrast to previous studies, we could not confirm 
decreased olfaction in patients with NC  [8–10] . The larg-
est and most recent study on the subject  [10] reported 
mild-to-moderate olfactory deficits in about 24% of 130 
narcoleptic patients (14% in healthy controls) when com-
pared to normative data. However, this finding was ob-
served only in one of the two centers of the study, i.e. the 
Italian one, where  only olfactory identification was tested 
by using the brief smell identification test (B-SIT). Test-
ing in the French center was performed using the whole 
Sniffin’Sticks set, including olfactory threshold, dis-
crimination, and identification. In fact, only discrimina-
tion testing (hence only one subtest composing the TDI 
score, which was used for comparison to normative data) 
produced significant differences between patients and 
control subjects. In other words, a higher prevalence of a 
mild olfactory identification deficit in NC was found in 
the Italian center, while a mild olfactory discrimination 
deficit was found in the French center using a different 
test.
 Different factors can explain the normal olfactory re-
sults that we found for NC patients. First, we report here 
on a small sample size. Second, as shown in the study 
cited above  [10] , hyposmia might be present in NC to a 
much lower extent than initially supposed. Third, it is 
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possible that NC patients present hyposmia only in rela-
tion to momentary EDS, making it harder to detect. This 
hypothesis is supported by two findings in our study: 
subjects that are sleepy at the time of testing tend to pro-
duce worse results, and untreated NC patients tend to 
produce worse results. If we follow this hypothesis we 
must note that, contrary to expectations, the NC patients 
in our study presented normal momentary sleepiness as 
well as normal olfaction.
 Limitations of the present study include the relatively 
small sample groups and an imperfect age and gender 
matching of control subjects. In addition, it must be not-
ed that our results for olfactory threshold testing with 
Sniffin’Sticks generally produced slightly lower scores 
than previously published normative data  [37] . These 
scores were nevertheless coherent between groups and 
corroborated by the presence of an own control group on 
one side, clear confirmation of results such as impaired 
olfaction in PD and decreased olfaction with older age on 
the other side.
 In summary we were not able to confirm the previ-
ously reported decreased olfaction in patients with NC, 
but our findings suggest that sleepiness is an important 
confounding factor that impairs olfaction testing.
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